Pacific Biosciences of California, Inc. (PACB) stock
PACBNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
$1.96−0.01 (-0.51%)
Close on Nov 13, 2026Market cap $609.23MP/E –Yield 0.00%
Pacific Biosciences of California total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Pacific Biosciences of California's total debt was $0 at Dec 31, 2024. For fiscal 2024 it was $0, down 100.0% from the year before. The highest annual figure on record is $16.11M in fiscal 2016.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $0 | -100.0% |
| FY2023 | Dec 31, 2023 | $490.00K | -79.1% |
| FY2022 | Dec 31, 2022 | $2.34M | -40.1% |
| FY2021 | Dec 31, 2021 | $3.91M | -73.3% |
| FY2018 | Dec 31, 2018 | $14.66M | +7.5% |
| FY2017 | Dec 31, 2017 | $13.64M | -15.3% |
| FY2016 | Dec 31, 2016 | $16.11M | +7.7% |
| FY2015 | Dec 31, 2015 | $14.95M | +6.8% |
| FY2014 | Dec 31, 2014 | $13.99M | +4.8% |
| FY2013 | Dec 31, 2013 | $13.35M | +379.1% |
| FY2012 | Dec 31, 2012 | $2.79M | -4.8% |
| FY2011 | Dec 31, 2011 | $2.93M | -3.7% |
| FY2010 | Dec 31, 2010 | $3.04M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2024 | Dec 31, 2024 | $0 | -100.0% |
| Q4 FY2023 | Dec 31, 2023 | $490.00K | -96.6% |
| Q4 FY2022 | Dec 31, 2022 | $2.34M | -83.4% |
| Q4 FY2021 | Dec 31, 2021 | $3.91M | -71.8% |
| Q4 FY2018 | Dec 31, 2018 | $14.66M | +7.5% |
| Q3 FY2018 | Sep 30, 2018 | $14.38M | +37.6% |
| Q2 FY2018 | Jun 30, 2018 | $14.12M | +35.2% |
| Q1 FY2018 | Mar 31, 2018 | $13.87M | +4.3% |
| Q4 FY2017 | Dec 31, 2017 | $13.64M | -15.3% |
| Q3 FY2017 | Sep 30, 2017 | $10.46M | – |
| Q2 FY2017 | Jun 30, 2017 | $10.44M | – |
| Q1 FY2017 | Mar 31, 2017 | $13.30M | – |
| Q4 FY2016 | Dec 31, 2016 | $16.11M | – |
See a number that looks wrong?